← Leaderboards
Paul R Carlier
Virginia Polytechnic Inst And St Univ
$6,583,641
Attributed
$9,477,230
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,477,230 · 8
By mechanism
R01$7,148,835 · 2
R21$1,327,265 · 3
U01$999,859 · 1
P41$1,271 · 2
Top collaborators
- Maria Belen Cassera7 shared
- John Paul Grieco2 shared
- Michael Klemba2 shared
- Seongcheol Kim1 shared
- Satish N Nadig1 shared
- John A Schetz1 shared
Most similar at Virginia Polytechnic Inst And St Univ
Same institution · by research overlap
- Michael Klemba$2,121,739
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureMalariaFundingToxic EffectUnited States National Institutes Of HealthResistancePharmacophoreVirtualOralLigandsBaseProbabilityResistance MechanismLifePreventTimelinePlasmodiumGrowthPlasmodium FalciparumPharmaceutical PreparationsParasitesLibrariesInfectionInnovation
Grant awards (21)
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)$999,859
U01 · FY2025 · GM
Optimization of antimalarials targeting multiple life stages of the parasite$688,004
R01 · FY2025 · AI · contact PI
Optimization of antimalarials targeting multiple life stages of the parasite$709,897
R01 · FY2024 · AI · contact PI
Optimization of antimalarials targeting multiple life stages of the parasite$60,972
R01 · FY2024 · AI · contact PI
Optimization of antimalarials targeting multiple life stages of the parasite$707,225
R01 · FY2023 · AI · contact PI
Optimization of antimalarials targeting multiple life stages of the parasite$75,947
R01 · FY2023 · AI · contact PI
Optimization of antimalarials targeting multiple life stages of the parasite$724,987
R01 · FY2022 · AI · contact PI
Optimization of antimalarials targeting multiple life stages of the parasite$768,193
R01 · FY2021 · AI · contact PI
Interrogating plasmodial endocytosis with mefloquine-based affinity probes$200,000
R21 · FY2021 · AI
Interrogating plasmodial endocytosis with mefloquine-based affinity probes$228,271
R21 · FY2020 · AI
Prevention of Zika transmission with novel Aedes personal protective measures$191,338
R21 · FY2018 · AI
Structure- and ligand-based design of new IspD-targeting antimalarials$185,600
R21 · FY2018 · AI · contact PI
Prevention of Zika transmission with novel Aedes personal protective measures$276,530
R21 · FY2017 · AI
Structure- and ligand-based design of new IspD-targeting antimalarials$245,526
R21 · FY2017 · AI · contact PI
Development of vector-specific, resistance-breaking insecticides to reduce malari$621,519
R01 · FY2013 · AI · contact PI
Development of vector-specific, resistance-breaking insecticides to reduce malari$661,190
R01 · FY2012 · AI · contact PI
Development of vector-specific, resistance-breaking insecticides to reduce malari$677,523
R01 · FY2011 · AI · contact PI
Development of vector-specific, resistance-breaking insecticides to reduce malari$722,567
R01 · FY2010 · AI · contact PI
MEDICINAL CHEMISTRY, CHEMICAL SYNTHESIS, AND MASS SPECTROMETRY$106
P41 · FY2010 · RR · contact PI
Development of vector-specific, resistance-breaking insecticides to reduce malari$730,811
R01 · FY2009 · AI · contact PI
MEDICINAL CHEMISTRY, CHEMICAL SYNTHESIS, AND MASS SPECTROMETRY$1,165
P41 · FY2009 · RR · contact PI